These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25633103)

  • 1. Detection of miRNA as non-invasive biomarkers of colorectal cancer.
    Ren A; Dong Y; Tsoi H; Yu J
    Int J Mol Sci; 2015 Jan; 16(2):2810-23. PubMed ID: 25633103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
    Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Cancer Biomarkers: Where Are We Now?
    Gonzalez-Pons M; Cruz-Correa M
    Biomed Res Int; 2015; 2015():149014. PubMed ID: 26106599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
    Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians.
    Phua LC; Chue XP; Koh PK; Cheah PY; Chan EC; Ho HK
    Oncol Rep; 2014 Jul; 32(1):97-104. PubMed ID: 24841830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers.
    Wu CW; Cao X; Berger CK; Foote PH; Mahoney DW; Simonson JA; Anderson BW; Yab TC; Taylor WR; Boardman LA; Kisiel JB; Ahlquist DA
    Dig Dis Sci; 2017 Aug; 62(8):1985-1994. PubMed ID: 28660489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer.
    Baassiri A; Nassar F; Mukherji D; Shamseddine A; Nasr R; Temraz S
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of colorectal cancer: from conventional methods to novel biomarkers.
    Vatandoost N; Ghanbari J; Mojaver M; Avan A; Ghayour-Mobarhan M; Nedaeinia R; Salehi R
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):341-51. PubMed ID: 25687380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
    Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
    PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for Stratification in Colorectal Cancer: MicroRNAs.
    Fadaka AO; Pretorius A; Klein A
    Cancer Control; 2019; 26(1):1073274819862784. PubMed ID: 31431043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.
    Lech G; Słotwiński R; Słodkowski M; Krasnodębski IW
    World J Gastroenterol; 2016 Feb; 22(5):1745-55. PubMed ID: 26855534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA dysregulation in colorectal cancer: a clinical perspective.
    Dong Y; Wu WK; Wu CW; Sung JJ; Yu J; Ng SS
    Br J Cancer; 2011 Mar; 104(6):893-8. PubMed ID: 21364594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer.
    Stefanescu H; Muntean D; Pilut C; Diaconu M; Popescu R; Hutanu D; Moise M; Diana L; Nitu R; Cherecheanu AP; Negoita S; Iovan CV; Ungureanu E; Calu V; Ciuca I
    Clin Lab; 2018 Mar; 64(3):257-262. PubMed ID: 29739108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.